(Q53140602)

English

How does inhibition of the renin-angiotensin system affect the prognosis of advanced gastric cancer patients receiving platinum-based chemotherapy?.

scientific article published on 8 October 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

How does inhibition of the renin-angiotensin system affect the prognosis of advanced gastric cancer patients receiving platinum-based chemotherapy?. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

object named as

Yeul Hong Kim

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

author name string

Seung Tae Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

Kyong Hwa Park

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

Sang Cheul Oh

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

Jae Hong Seo

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

Jun Suk Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

Sang Won Shin

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

publication date

8 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

83

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

354-360

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

Gastric cancer epidemiology and risk factors

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

The role of chemotherapy in the current treatment of gastric cancer

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark.

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

The renin-angiotensin system and malignancy

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis?

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer.

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Blockade of the renin-angiotensin-aldosterone system: effects on hypertensive target organ damage

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancer.

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Angiotensin receptors: a new role in cancer?

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats

1 reference

https://api.crossref.org/works/10.1159%2F000337979

21 January 2018

Identifiers

10.1159/000337979

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23052034

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53140602&oldid=2169609444"